2023-09-20
September 21, is World Alzheimer's Day, which aims to draw attention to and raise awareness about Alzheimer's disease. In connection with World Alzheimer’s Day, our CEO Kristina Torfgård is interviewed by Redeye about the Company's latest advances and developments in…
Read more
2023-09-11
Alzinova's CEO Kristina Torfgård shares her reflections on all the important progress the company has made during the year,… Read more
2023-09-05
September marks the start of World Alzheimer's awareness month. Let's take a moment to reflect on the impact of… Read more
2023-06-12
Last week, our CEO, Kristina Torfgård, and Business Development Director, Sebastian Hansson, participated in one of the major biotech… Read more
2023-06-09
We are delighted to have participated in and sponsored Alzheimerfonden and this year's Alzheimer's Run, a significant event in raising awareness… Read more
2023-05-29
Our CEO Kristina Torfgård and Business Development Director Sebastian Hansson will be at BIO 2023 in Boston 5-8th June. Read more
2023-04-24
Alzinova is currently in the subscription period for warrants of series TO3. Alzinova has already secured subscription commitments of… Read more
2023-04-20
The presentation highlighted the latest advancements in the company's groundbreaking research on Alzheimer's disease. Check it out to learn… Read more
2023-04-05
Updated analysis from Mangold Fondkommission based on the recent milestones achieved by Alzinova that further strengthens the case for the Company. … Read more
2023-04-03
Anders tells more about the new exciting data for the vaccine candidate ALZ-101 and the ADPD conference. Read more
2023-03-29
Alzinovas CEO Kristina Torfgård attended Mangold Insight Day and held an investor presentation. Read more
2023-03-23
Exciting news about the filing of a new patent application for a further developed form of its monoclonal antibody… Read more
2023-03-03
2022 was a year of many successes, with several important milestones achieved. CEO Kristina Torfgård comments the year-end report and… Read more
2023-02-10
Read why Sebastian joined the company and what his mission will be at Alzinova AB. Read more
2023-01-27
Sebastian will be responsible for the continued business development that runs parallel to the further development of the Company's… Read more
2023-01-18
Kristina Torfgård, CEO, commenting on recent exciting events for both the company and the industry in general. Read more
2023-01-13
Alzinova's CEO Kristina Torfgård was interviewed about the accelerated approval of lecanemab… Read more
2023-01-05
Anders tells more about the new exciting data for ALZ-201 antibody and the findings and conclusions as well as… Read more
2023-01-04
In the prestigious journal Alzheimer's Research & Therapy, Alzinova presents preclinical results demonstrating that the ALZ-201 antibody has specificity… Read more
2022-12-23
Alzinova's CEO Kristina Torfgård was interviewed about the latest news on the Companies vaccine candidate ALZ-101 against Alzheimer's disease. Read more
2022-12-19
Watch our CEO Kristina Torfgård, present Alzinova (in Swedish). Read more
2022-12-02
Alzinova's CSO Anders Sandberg was interviewed about the Companies monoclonal antibody ALZ-201 that is presented in a poster presentation… Read more
2022-11-30
This week, Alzinova presents data for the Company's preclinical antibody candidate ALZ-201 at the conference in a poster presentation… Read more
2022-11-15
Alzinova AB presents its company and projects to investors and international pharmaceutical companies at several events during the fall. Next… Read more
2022-11-14
“We see that this outcome proves and further strengthens the company's research because we already have indications that specificity… Read more
2022-11-11
Alzinova is featured in this Sifted article where CEO Kristina Torfgård comments the importance of research hubs such as the AZ BioVentureHub. Read more
2022-11-04
2022-10-24
Watch the new interview (in Swedish). Read more
2022-10-14
2022-10-13
Mangold sees the case for Alzinova's ALZ-101 candidate strengthened considerably. In an updated analysis, Mangold sees advantages in Alzinova's… Read more
2022-09-30
We are happy to see progress in the field of Alzheimer research with new results in the industry that… Read more
2022-09-14
Alzinova AB is a proud sponsor of Alzheimerfonden and will participate in their seminar the 21st of September 2022. CEO Kristina Torfgård together with… Read more
2022-09-07
The company announced that the Data Safety Monitoring Board (DSMB) completed an additional planned safety assessment of the ongoing… Read more
2022-09-01
September marks the start of World Alzheimer's awareness month. It's important to highlight and bring awareness to this devastating… Read more
2022-07-12
Redeye discussed the outlook forward and recent rights issue, among other things. "We believe that Alzinova offers a rare… Read more
2022-06-21
Redeye AB has revisited the Alzinova equity story following continued pipeline progress and the recent rights issue: "We continue to see… Read more
2022-06-13
Alzinova is collaborating with researchers at Sahlgrenska University Hospital in Gothenburg regarding biomarker research for neurodegenerative changes in Alzheimer's disease. Read more
2022-06-08
On June 8, our CEO, Kristina Torfgård, presented at BioStock Life Science Spring Summit. Read more
2022-06-07
Kristina Torfgård, CEO, and Anders Sandberg, CSO, were interviewed by the podcast "Fill or Kill". Read more
2022-06-03
Kristina visited Biostock's studio to talk about how Alzinova differs from other companies developing treatments for Alzheimer's disease. She… Read more
2022-06-02
Alzinova recently participated in the Redeye Growth Day 2 June 2022. Check out the Q&A session with our CEO,… Read more
2022-06-01
Alzinova has taken the next important step to take ALZ-201 towards clinical studies by initiating the development of a… Read more
2022-05-30
”Attempts to develop effective drugs for Alzheimer's disease have been going on for several decades, but so far no… Read more
2022-05-20
Kristina Torfgård, our CEO, presented Alzinova at Aktieportföljen Live on May 11. Read more
2022-05-11
We are proud to sponsor the Alzheimer race, which takes place this weekend, May 13-15. Read more
2022-05-04
"Alzinova lägger grunden för nästa utvecklingssteg"… Read more
On May 3, Kristina Torfgård, CEO, and Anders Sandberg, CSO participated in a panel discussion on Alzheimer's disease. Read more
2022-04-14
In the article (in Swedish) linked below, our CEO, Kristina Torfgård, comments on the recent decision by the the… Read more
2022-04-10
Anders Sandberg, Chief Scientific Officer, about our improved manufacturing process for our oligomer-specific vaccine, ALZ-101. Read more
2022-03-16
We are proud to be part of the BioVentureHub on the AstraZeneca Gothenburg site in the wider GoCo Health… Read more
2022-02-04
Kristina Torfgård, CEO, Anders Sandberg, CSO, and Håkan Skogström, CFO, were interviewed by our Communications Specialist, Jamie Smith, at… Read more
